Efficacy and Implementation of MINDxYOU Program for Reducing Stress and Promote Mental Health Among Healthcare Providers

Overview

Because of the COVID-19 pandemic situation, social and health professionals constitute a population in risk of developing psychopathologies due to the high levels of stress they experience. There is consensus regarding the need of offering these professionals psychotherapeutic evidence-based interventions addressed to reducing their stress levels and promote their wellbeing; because of the current situation, it is believed that online interventions might be the best-fitted approach. The research groups that present this project have leaded a research line that has proved the efficacy of online psychotherapeutic programs in the past. In the present project, the efficacy of the MINDxYOU program will be evaluated; this is an online intervention based on mindfulness techniques, compassion, and acceptance, and that has been developed specifically for social and health professionals. In addition, in order to overcome the gap that separates the validation of interventions and their posterior implementation, this project aims to perform an implementation study in which a hybrid design will be adopted to test the impact of the program in terms of efficacy and the feasibility of the implementation. The investigators will adopt the framework proposed by Hermes. et al., inspired in Proctor's recommendations. The study will be conducted in 2 autonomous communities (Aragón and Andalucía).

Full Title of Study: “Efficacy and Implementation of an Online Mindfulness and Compassion-based Program (MINDxYOU) for Reducing Stress and Promote Mental Health Among Healthcare Providers in Spain”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: N/A
    • Intervention Model: Single Group Assignment
    • Primary Purpose: Treatment
    • Masking: None (Open Label)
  • Study Primary Completion Date: December 15, 2023

Interventions

  • Behavioral: MINDxYOU
    • The online program MINDxYOU is based on the principles of ‘third wave’ psychotherapies and it is an online program particularly addressed at healthcare providers which will both monitor and support the individual’s mental health. The program is self-administered and will be delivered via the Internet and available via smartphone, tablet, and personal computer.

Arms, Groups and Cohorts

  • Experimental: MINDxYOU
    • The online program MINDxYOU is based on the principles of ‘third wave’ psychotherapies, such as the promotion of wellbeing through the practice of mindfulness, compassion, acceptance, and spirituality and the estimated time for completing the whole program is 8 weeks

Clinical Trial Outcome Measures

Primary Measures

  • Perceived Stress Scale (PSS)
    • Time Frame: Baseline
    • Consists of 10 items in which participants are asked to rate how unpredictable, uncontrollable, and overloaded they have found their life over the past month on a 5-point Likert-type scale. Scores range from 0 to 40, and higher scores reflect higher levels of perceived stress.
  • Perceived Stress Scale (PSS)
    • Time Frame: Post-treatment 10 weeks from baseline
    • Consists of 10 items in which participants are asked to rate how unpredictable, uncontrollable, and overloaded they have found their life over the past month on a 5-point Likert-type scale. Scores range from 0 to 40, and higher scores reflect higher levels of perceived stress.
  • Perceived Stress Scale (PSS)
    • Time Frame: 6 months follow-up from baseline
    • Consists of 10 items in which participants are asked to rate how unpredictable, uncontrollable, and overloaded they have found their life over the past month on a 5-point Likert-type scale. Scores range from 0 to 40, and higher scores reflect higher levels of perceived stress.

Secondary Measures

  • Patient Health Questionnaire (PHQ-9)
    • Time Frame: Baseline
    • It is a 9-item scale aimed at screening for depression in primary care and other medical settings. It assesses the frequency of depressive symptoms during the last 2 weeks using a scale from 0 (not at all) to 3 (nearly every day). The total score ranges from 0 to 27, with higher scores indicating higher severity of depression.
  • Patient Health Questionnaire (PHQ-9)
    • Time Frame: Post-treatment 10 weeks from baseline
    • It is a 9-item scale aimed at screening for depression in primary care and other medical settings. It assesses the frequency of depressive symptoms during the last 2 weeks using a scale from 0 (not at all) to 3 (nearly every day). The total score ranges from 0 to 27, with higher scores indicating higher severity of depression.
  • Patient Health Questionnaire (PHQ-9)
    • Time Frame: 6 months follow-up from baseline
    • It is a 9-item scale aimed at screening for depression in primary care and other medical settings. It assesses the frequency of depressive symptoms during the last 2 weeks using a scale from 0 (not at all) to 3 (nearly every day). The total score ranges from 0 to 27, with higher scores indicating higher severity of depression.
  • General Anxiety Disorder-7 (GAD-7)
    • Time Frame: Baseline
    • It is a 7-item self-reported measure to assess the intensity of anxiety symptoms. It refers to the period of the past 2 weeks; each item is scored in a 4-point Likert-type scale, resulting in a total score that can range from 0 to 21, with higher values reflecting more severe anxiety symptoms.
  • General Anxiety Disorder-7 (GAD-7)
    • Time Frame: Post-treatment 10 weeks from baseline
    • It is a 7-item self-reported measure to assess the intensity of anxiety symptoms. It refers to the period of the past 2 weeks; each item is scored in a 4-point Likert-type scale, resulting in a total score that can range from 0 to 21, with higher values reflecting more severe anxiety symptoms.
  • General Anxiety Disorder-7 (GAD-7)
    • Time Frame: 6 months follow-up from baseline
    • It is a 7-item self-reported measure to assess the intensity of anxiety symptoms. It refers to the period of the past 2 weeks; each item is scored in a 4-point Likert-type scale, resulting in a total score that can range from 0 to 21, with higher values reflecting more severe anxiety symptoms.
  • Brief Symptoms Inventory (BSI)
    • Time Frame: Baseline
    • It is a 18-item self-reported questionnaire designed to offer a rapid screening of symptoms of psychological disorders. Each item is scored in a 5-point Likert-type scale, reflecting on the past 7 days.
  • Brief Symptoms Inventory (BSI)
    • Time Frame: Post-treatment 10 weeks from baseline
    • It is a 18-item self-reported questionnaire designed to offer a rapid screening of symptoms of psychological disorders. Each item is scored in a 5-point Likert-type scale, reflecting on the past 7 days.
  • Brief Symptoms Inventory (BSI)
    • Time Frame: 6 months follow-up from baseline
    • It is a 18-item self-reported questionnaire designed to offer a rapid screening of symptoms of psychological disorders. Each item is scored in a 5-point Likert-type scale, reflecting on the past 7 days.
  • Connor-Davidson Resilience Scale (CD-RISC)
    • Time Frame: Baseline
    • It is a 10-item self-reported measure addressed at assessing resilience. Each item is scored in a 5-point Likert scale, and the total score, which ranges from 1 to 5, is calculated by averaging the scores of the items; higher scores indicate higher levels of resilience.
  • Connor-Davidson Resilience Scale (CD-RISC)
    • Time Frame: Post-treatment 10 weeks from baseline
    • It is a 10-item self-reported measure addressed at assessing resilience. Each item is scored in a 5-point Likert scale, and the total score, which ranges from 1 to 5, is calculated by averaging the scores of the items; higher scores indicate higher levels of resilience.
  • Connor-Davidson Resilience Scale (CD-RISC)
    • Time Frame: 6 months follow-up from baseline
    • It is a 10-item self-reported measure addressed at assessing resilience. Each item is scored in a 5-point Likert scale, and the total score, which ranges from 1 to 5, is calculated by averaging the scores of the items; higher scores indicate higher levels of resilience.
  • Five Facets of Mindfulness Questionnaire -15 item version (FFMQ-15)
    • Time Frame: Baseline
    • It is an adaptation of the original 39-item FFMQ, a questionnaire addressed at measuring the five facets of mindfulness. Each subscale of the FFMQ-15 includes 3 items, scored in a Likert-type scale (1-5). A score for each subscale, ranging from 5 to 15, can be computed by summing the items, where higher scores indicate higher levels of the mindfulness facet.
  • Five Facets of Mindfulness Questionnaire -15 item version (FFMQ-15)
    • Time Frame: Post-treatment 10 weeks from baseline
    • It is an adaptation of the original 39-item FFMQ, a questionnaire addressed at measuring the five facets of mindfulness. Each subscale of the FFMQ-15 includes 3 items, scored in a Likert-type scale (1-5). A score for each subscale, ranging from 5 to 15, can be computed by summing the items, where higher scores indicate higher levels of the mindfulness facet.
  • Five Facets of Mindfulness Questionnaire -15 item version (FFMQ-15)
    • Time Frame: 6 months follow-up from baseline
    • It is an adaptation of the original 39-item FFMQ, a questionnaire addressed at measuring the five facets of mindfulness. Each subscale of the FFMQ-15 includes 3 items, scored in a Likert-type scale (1-5). A score for each subscale, ranging from 5 to 15, can be computed by summing the items, where higher scores indicate higher levels of the mindfulness facet.
  • Sussex-Oxford Compassion Scales (SOCS)
    • Time Frame: Baseline
    • This scale is composed by two 20-item self-report scales measuring compassion. A total score, ranging from 20 to 100, is calculated for each scale, and higher total values indicate higher levels of compassion
  • Sussex-Oxford Compassion Scales (SOCS)
    • Time Frame: Post-treatment 10 weeks from baseline
    • This scale is composed by two 20-item self-report scales measuring compassion. A total score, ranging from 20 to 100, is calculated for each scale, and higher total values indicate higher levels of compassion
  • Sussex-Oxford Compassion Scales (SOCS)
    • Time Frame: 6 months follow-up from baseline
    • This scale is composed by two 20-item self-report scales measuring compassion. A total score, ranging from 20 to 100, is calculated for each scale, and higher total values indicate higher levels of compassion
  • Acceptance and Action Questionnaire-II (AAQ-II)
    • Time Frame: Baseline
    • It is a measure for assessing experiential avoidance, a key element of ‘third wave’ psychotherapies that refers to the tendency to avoid thoughts, feelings, memories, sensations and other internal experiences, and which is very commonly associated with worse mental health outcomes, as opposite to psychological flexibility. The scale presents 7 items scored in a 7-point Likert-type scale, and a total score is calculated by summing all the items. Higher scores mean higher experiential avoidance.
  • Acceptance and Action Questionnaire-II (AAQ-II)
    • Time Frame: Post-treatment 10 weeks from baseline
    • It is a measure for assessing experiential avoidance, a key element of ‘third wave’ psychotherapies that refers to the tendency to avoid thoughts, feelings, memories, sensations and other internal experiences, and which is very commonly associated with worse mental health outcomes, as opposite to psychological flexibility. The scale presents 7 items scored in a 7-point Likert-type scale, and a total score is calculated by summing all the items. Higher scores mean higher experiential avoidance.
  • Acceptance and Action Questionnaire-II (AAQ-II)
    • Time Frame: 6 months follow-up from baseline
    • It is a measure for assessing experiential avoidance, a key element of ‘third wave’ psychotherapies that refers to the tendency to avoid thoughts, feelings, memories, sensations and other internal experiences, and which is very commonly associated with worse mental health outcomes, as opposite to psychological flexibility. The scale presents 7 items scored in a 7-point Likert-type scale, and a total score is calculated by summing all the items. Higher scores mean higher experiential avoidance.
  • EuroQol five-dimensional classification system (EQ-5D)
    • Time Frame: Baseline
    • It is a widely used health-related quality of life measure. First, the participant is asked to report how severe (1= no problems, 2= mild, 3= moderate, 4= severe, 5= extreme) are the problems they may present in the day of reporting regarding each of the following five domains: mobility, self-care, usual activities, pain, and anxiety/depression. The utility scores are obtained from the EQ-5D classification system and are used to rate patients’ health-related quality of life, which normally range from 0 (although it is possible to present negative scores) to 1 (i.e., “perfect health”).
  • EuroQol five-dimensional classification system (EQ-5D)
    • Time Frame: 6 months follow-up from baseline
    • It is a widely used health-related quality of life measure. First, the participant is asked to report how severe (1= no problems, 2= mild, 3= moderate, 4= severe, 5= extreme) are the problems they may present in the day of reporting regarding each of the following five domains: mobility, self-care, usual activities, pain, and anxiety/depression. The utility scores are obtained from the EQ-5D classification system and are used to rate patients’ health-related quality of life, which normally range from 0 (although it is possible to present negative scores) to 1 (i.e., “perfect health”).
  • Client Service Receipt Inventory (CSRI)
    • Time Frame: Baseline
    • It is addressed at describe and measure service utilization patterns as a basis for estimating associated costs across healthcare, social care and community settings.
  • Client Service Receipt Inventory (CSRI)
    • Time Frame: 6 months follow-up from baseline
    • It is addressed at describe and measure service utilization patterns as a basis for estimating associated costs across healthcare, social care and community settings.
  • System Usability Scale (SUS)
    • Time Frame: Post-treatment 10 weeks from baseline
    • It is a 10-item questionnaire to measure the usability which qualitatively is related with the quality and acceptability of the intervention. The scale presents 5-point Likert-type scale (0 = never, 1 = almost never, 2 = often, 3 = sometimes and 4 = always). A total score, ranging from 0 to 40, is calculated by totalling the scores from all the items, and higher total values indicate higher level of acceptability of the intervention
  • Client Satisfaction Questionnaire adapted to Internet-Based interventions (CSQ-I)
    • Time Frame: Post-treatment 10 weeks from baseline
    • It is an 8-item, 4-point Likert scale questionnaire that assesses the general satisfaction of the participants regarding the received intervention. The total score ranges from 8 to 32.
  • Intervention Appropriateness Measure (IAM)
    • Time Frame: Post-treatment 10 weeks from baseline
    • Includes 4 items designed to measure appropriateness of the intervention. The scale presents 5-point Likert-type scale (1 = completely disagree, 2 = in disagreement, 3 = neither agree nor disagree, 4 = agree and 5 = completely agree). A total score, ranging from 0 to 20, is calculated by totalling the scores from all the items, and higher total values indicate higher level of appropriateness of the intervention
  • Attitudes towards Psychological Online Interventions (APOI)
    • Time Frame: Post-treatment 10 weeks from baseline
    • Includes 16 items to assess attitudes toward online interventions among people with depressive symptomatology. The APOI explores four dimensions; “Skepticism and Perception of Risks”, “Confidence in Effectiveness”, “Technologization Threat” and “Anonymity Benefits”. Each factor is calculated from the sum of 4 specific items. The scale presents 5-point Likert-type scale (1 = totally agree, 2 = agree, 3 = I’m not sure, 4 = disagree and 5 = totally disagree). Each factor can get a score between 4-20 points, and the higher the score, the greater the sensation perceived by the participant in each of the factors.

Participating in This Clinical Trial

Inclusion Criteria

  • Working as a doctor, nurse, physiotherapist, psychologist, nursing assistant, ambulance technician, or being a trainee student in any health profession, or working in a nursing home. – Aged between 18 and 70. – Ability to understand Spanish. – Digital literacy and access to a smartphone, tablet, or personal computer with Internet connection. – Giving informed consent. Exclusion Criteria:

  • Presenting an illness that affects the central nervous system. – Having a diagnosis of a severe psychiatric condition (including severe depressive disorders, suicidal tendencies, bipolar disorders, panic disorders, anxiety or stress-related disorders, obsessive-compulsive disorders, and substance-related disorders). – Presenting a medical, infectious, or degenerative illness that is not under control.

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: 70 Years

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • Hospital Miguel Servet
  • Provider of Information About this Clinical Study
    • Principal Investigator: Javier Garcia Campayo, Principal Investigator – Hospital Miguel Servet

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.